| Resistance to chemotherapy and metastatic tumor growth are major factors thatdirectly lead to the demise of cancer patients. My laboratory studies the regulation of 2 proteins that directly affect tumor cell death (RKIP) and survival (STAT3). We have found that RKIP is a negative regulator of STAT3. We are validating if RKIP is a candidate to be utilized as the basis for molecular-targeted therapeutic strategy for cancer. |
DEVASIS CHATTERJEE, PHD http://research.brown.edu/myresearch/Devasis_Chatterjee Brown collaborators:Collaborators at other institutions: Are you Devasis Chatterjee? Click here to edit your research profile. |